HIV10

About the Program

Program Overview
Target Audience
Learning Objectives
Course Director and Moderator
Faculty
Accreditation Statement
Credit Designation
Disclosure of Conflicts of Interest
Disclosure of Unlabeled Use
Instructions for Participation and Credit
Disclaimer

Program Overview

This 1.5-hour On-Demand Internet symposium will review and discuss the key studies on antiretroviral therapy presented during 2010 and at HIV10. The symposium will feature 4 well-known and recognized thought leaders in the HIV field, with 3 serving as presenting faculty/discussants and 1 as program moderator. This activity has been designed to meet the educational needs of physicians involved in the care of patients with HIV infection.

This program is certified for CME credit for US physicians by the Annenberg Center for Health Sciences at Eisenhower.

Target Audience

This activity has been designed to meet the educational need of physicians involved in the care of patients with HIV infection.

Learning Objectives

After completing this activity, participants should be able to:

Explain the key new studies on ARV therapy presented during 2010 and at HIV10
Employ the advances in clinical management of HIV-positive patients presented and discussed during 2010 and at HIV10
Apply data presented during 2010 and at HIV10 regarding the treatment of ARV-naïve and experienced patients

Release Date: November 16, 2010
Expiration Date: November 16, 2011

Estimated time to complete the On-Demand HIV10 Web Symposium: 1 hour, 30 minutes

Media: Internet

Course Director and Moderator

Calvin J. Cohen, MD, MS
Research Director,
CRI New England
Clinical Instructor,
Harvard Medical School
Boston, Massachusetts

Faculty

Jose Arribas, MD,
Senior Attending Physician, HIV Unit
Hospital de La Paz
Madrid, Spain

Jurgen Rockstroh, MD
Professor, University of Bonn
Bonn, Germany

Graeme Moyle, MD, MB, BS
Associate Director of HIV Research
Chelsea & Westminster Hospital
London, UK

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Annenberg Center for Health Sciences at Eisenhower (Annenberg Center) and ViralEd, LLC. The Annenberg Center is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Annenberg Center designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

The Annenberg Center assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Dr. Calvin Cohen:

Contracted Research: Gilead; Bristol-Myers Squibb; Merck & Co.; Tibotec; ViiV
Consulting Fees: Gilead; Bristol-Myers Squibb; Merck & Co.; Tibotec; Abbott
Speakers Bureau: Gilead; Bristol-Myers Squibb; Merck & Co.; Tibotec

Dr. Graeme Moyle:

Consulting Fees: Astellas; Bristol-Myers Squibb; Gilead; Tibotec; Merck & Co., ViiV
Speakers Bureau: Astellas; Bristol-Myers Squibb; Gilead; Tibotec; Merck & Co., ViiV

Dr. Juergen Rockstroh:

Contracted Research: Abbott; Merck & Co.; Roche
Consulting Fees: Abbott; Bristol-Myers Squibb; Boerhringer Ingelheim; Merck & Co.; Roche; GlaxoSmithKline; Pfizer; Gilead; ViiV

Jose Arribas, MD

Consulting Fees: Merck; Abbott; Tibotec; Janssen; Gilead; GlaxoSmithKline; Pfizer; Biogen; Avexa; Bristol-Myers Squibb; ViiV

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following planners and managers, Jan Hixon, RN, BSN, MA; Trace Hutchison, PharmD; Julia Kimball, RN, BSN; Samantha Mattiucci, PharmD; Jan Schultz, RN, MSN, CCMEP; Patricia Staples, MSN, NP-C, CCRN and Gordon West, PhD, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Annenberg Center, Postgraduate Institute for Medicine (PIM), ViralEd, LLC and Merck & Co. do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Annenberg Center, PIM, ViralEd, LLC and Merck & Co. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Instructions for Participation and Credit

There are no fees for participating and receiving credit for this activity. During the period, November 16, 2010 through November 16, 2011, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the post-test and evaluation form.

To answer the questions, click on your selected choice for each answer then proceed to the next question. We recommend that you print a copy of your answers before you submit them to us. Once completed, click on the Submit Post-test at the bottom of the page. Your post-test will automatically be graded.

If you successfully complete the post-test (score of 70% or higher). your certificate will be made available immediately. Click on View Certificate and print the certificate for your records. If you received a score of 69% or less, you will receive a message notifying you that you did not pass the post-test. You may retake the post-test until successful.

You may complete the Post-test on-line at www.cmeuniversity.com

Click on "Find Post-Test/Evaluation by Course" on the navigation menu
Search by project ID: 7514
Upon successfully completing the Post-test and Evaluation form, your certificate will be made available immediately.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.